Date
August 13, 2025
Reading Time
4 minutes
Share
Full-thickness macular holes (FTMH) can lead to significant central vision loss. Thanks to modern vitreoretinal surgical techniques, both anatomical closure and visual outcomes have improved significantly. This article provides a structured overview of current surgical approaches, success rates, and clinical considerations. All based on recent scientific evidence.

MFTMHs are commonly idiopathic, but can also result from high myopia, tractional forces, or inflammatory disease. The standard treatment involves pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and gas tamponade, resulting in closure rates of ~90-95% for holes <400 µm B38.
However, for large or chronic holes, closure rates drop significantly to around 60-80% B39.
For large macular holes (>400-500 µm), the inverted ILM flap technique is now widely accepted. The ILM is not completely removed but is folded over the hole to serve as a scaffold for retinal gliosis and repair B40.
In cases where local ILM is absent (e.g. revisions), free ILM flaps can be transplanted – yielding closure rates of ~86% B42.
The "Cover" vs. "Fill" technique variants show similar anatomical outcomes, but the Cover method may lead to faster visual recovery and better fixation B43.
MFTMHs are commonly idiopathic, but can also result from high myopia, tractional forces, or inflammatory disease. The standard treatment involves pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and gas tamponade, resulting in closure rates of ~90-95% for holes <400 µm B38.
However, for large or chronic holes, closure rates drop significantly to around 60-80% B39.

Modern macular hole surgery relies not only on surgical skill and technique - but also on precision instrumentation and fluidic control. In this context, the choice of vitrectomy platform can directly impact safety, flap manipulation, and tamponade stability.
Oertli’s surgical platforms, such as the OS 4 Up and Faros systems, are designed with these challenges in mind.
These capabilities makes the OS 4 Up and Faros a highly suitable device for performing vitreoretinal macular hole surgery B1.
Share